Abstract
Background
Non-variceal upper gastrointestinal bleeding (NVUGIB) in non-ST-elevation myocardial infarction (NSTEMI) is associated with substantial morbidity and mortality. We evaluated inpatient outcomes of esophagogastroduodenoscopy (EGD) before cardiac catheterization in patients with NSTEMI and NVUGIB.
Methods
We utilized the National Readmission Database (2016–2019) to identify all index hospitalizations with a primary diagnosis of NSTEMI and a secondary diagnosis of NVUGIB that underwent EGD before cardiac catheterization (cases). A matched comparison cohort of similar hospitalizations that undergo EGD after cardiac catheterization were identified (controls) after 1:1 propensity score matching for age, gender, cardiac comorbidities, causes, and severity of bleeding.
Results
A total of 796 cases were matched with 796 controls. There was a higher median length of hospital stay (8 vs. 5 days, P = 0.01) and median hospital charges ($111,218 vs. $99,115, P = 0.002) for cases compared to controls. There was a higher all-cause inpatient mortality in cases compared to controls (5.5% vs. 3.9%, P = 0.26). Furthermore, there was a higher proportion of patients with ICU admission (7% vs. 3%, P < 0.001), septic shock (7.1% vs. 5.8%, P = 0.41), atrial fibrillation (27.1% vs. 19.8%, P < 0.001) and acute kidney injury (42.8% vs. 29.1%, P < 0.001) for cases compared to controls.
Conclusion
Delaying cardiac catheterization in favor of EGD is associated with increased hospital stay, costs, and cardiac complications. Further studies are warranted to establish our findings.
Similar content being viewed by others
Change history
02 November 2023
A Correction to this paper has been published: https://doi.org/10.1007/s10620-023-08160-4
Abbreviations
- NVUGIB:
-
Non-variceal upper gastrointestinal bleeding
- NSTEMI:
-
Non-ST elevation myocardial infarction
- EGD:
-
Esophagogastroduodenoscopy
- NRD:
-
National Readmission Database
- NIS:
-
National inpatient sample
- ACS:
-
Acute coronary syndrome
- STEMI:
-
ST elevation myocardial infarction
- PCI:
-
Percutaneous coronary intervention
- PUD:
-
Peptic ulcer disease
- UGIB:
-
Upper GI bleed
- ASGE:
-
American Society of Gastroenterology
- US:
-
United States
- HCUP:
-
Agency for Healthcare Research and Quality Healthcare Cost and Utilization Project
- ICD:
-
International Classification of Diseases
- STATA:
-
Statistical software for data science
- IQR:
-
Interquartile range
- CI:
-
95% Confidence interval
- ICU:
-
Intensive care unit
- AKI:
-
Acute kidney injury
- OR:
-
Odds ratio
References
Cohen M, Visveswaran G. Defining and managing patients with non-ST-elevation myocardial infarction: sorting through type 1 vs other types. Clin Cardiol 2020;43:242–250.
Ahrens I, Averkov O, Zúñiga EC et al. Invasive and antiplatelet treatment of patients with non-ST-segment elevation myocardial infarction: understanding and addressing the global risk-treatment paradox. Clin Cardiol 2019;42:1028–1040.
Lin S, Konstance R, Jollis J, Fisher DA. The utility of upper endoscopy in patients with concomitant upper gastrointestinal bleeding and acute myocardial infarction. Dig Dis Sci 2006;51:2377–2383.
Yachimski P, Hur C. Upper endoscopy in patients with acute myocardial infarction and upper gastrointestinal bleeding: results of a decision analysis. Dig Dis Sci 2009;54:701–711.
ASGE Standards of Practice Committee, Acosta RD, Abraham NS, et al. The management of antithrombotic agents for patients undergoing GI endoscopy. Gastrointest Endosc 2016; 83: 3–16.
Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71–86.
Weintraub WS, Mahoney EM, Lamy A et al. Long-term cost-effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation. J Am Coll Cardiol 2005;45:838–845.
Eikelboom JW, Anand SS, Malmberg K, Weitz JI, Ginsberg JS, Yusuf S. Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis. Lancet 2000;355:1936–1942.
Wong GC, Giugliano RP, Antman EM. Use of low-molecular-weight heparins in the management of acute coronary artery syndromes and percutaneous coronary intervention. JAMA 2003;289:331–342.
Boersma E, Akkerhuis KM, Théroux P, Califf RM, Topol EJ, Simoons ML. Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: early benefit during medical treatment only, with additional protection during percutaneous coronary intervention. Circulation 1999;100:2045–2048.
Mehta SR, Cannon CP, Fox KAA et al. Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. JAMA 2005;293:2908–2917.
Spencer FA, Moscucci M, Granger CB et al. Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction? Circulation 2007;116:2793–2801.
Eikelboom JW, Mehta SR, Anand SS, Xie C, Fox KAA, Yusuf S. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation 2006;114:774–782.
Lim RG, Cobell WJ, Theivanayagam S et al. Endoscopy after acute myocardial infarction: an evaluation of safety. South Med J 2013;106:545–549.
HCUP-US NIS Overview. Available from: https://www.hcup-us.ahrq.gov/nisoverview.jsp.
Khera R, Angraal S, Couch T et al. Adherence to methodological standards in research using the national inpatient sample. JAMA 2017;318:2011–2018.
Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med 2009;28:3083–3107.
Ali H, Shamoon S, Bolick NL, et al. Outcomes of endoscopic retrograde cholangiopancreatography-guided gallbladder drainage compared to percutaneous cholecystostomy in acute cholecystitis. Ann Hepatobiliary Pancreat Surg (Published online December 20, 2022).
Funding
The authors report no external funding.
Author information
Authors and Affiliations
Contributions
HA, PP, WL, BPM Conceptualization, Methodology, Software, Data curation, Validation, Writing—Original draft preparation. HA, JL, DSD, ASH, SP: Writing—Reviewing and Editing, Project administration. HA, DSD, DGA, BPM: Writing—Reviewing and Editing, Supervision.
Corresponding author
Ethics declarations
Conflict of interest
The authors certify that they have NO affiliations with or involvement in any organization or entity with any financial interest. The authors declare that they have no conflicts of interest.
Ethical approval
Institutional IRB approval was not obtained for this study as the nationwide readmission database is a third party de-identified retrospective database which is publicly accessible.
Informed consent
Not required due to retrospective de-identified data analysis.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
An editorial commenting on this article is available at https://doi.org/10.1007/s10620-023-08040-x.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Ali, H., Patel, P., Lowell, J. et al. Delaying Cardiac Catheterization in Favor of Endoscopy in Non-ST Elevation Myocardial Infarction Patients Is Associated with Worse Outcomes: A Nationwide Analysis. Dig Dis Sci 68, 3913–3920 (2023). https://doi.org/10.1007/s10620-023-08033-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-023-08033-w